View Systems, Inc.'s (VSYM), Medical Therapeutics Reports Agreements with Major Credit Facilities
BALTIMORE, MD, June 20, 2018 (GLOBE NEWSWIRE) -- View Systems, Inc. (OTC:VSYM) today announced that its new medical division, Medical Therapeutics, a concierge medical service providing sexual health therapies, has been approved by three of the largest credit providing facilities. Male enhancement is a $7.6 Billion growth market.
William Kelly, Director of Operations, states, "We have recently been approved by three of the largest patient financing companies to offer credit options to our patients when they are not covered by their medical health insurance. In many cases these options are interest free. Sexual health is not something that insurance companies routinely support. Our therapy programs have been so successful that we guarantee positive results for our patients or do not charge for their visit. Our propriety formulations use FDA approved medicines. Our success rate has been more than 90% plus effective."
According to Pew Research, 10,000 Baby Boomers turn 65 years every day, of which 49% (approximately 4,900) are male.This trend ensures that Medical Therapeutics will continue to see an expanding pool of prospective patients, ensuring the anticipated growth of our business. Common problems are: diabetes, high blood pressure, prostate difficulties, side effects of prescription drugs, testosterone decline and cardiovascular issues.
On the heels of a profitable last quarter, Medical Therapeutics’ patient base has doubled in the Baltimore/Washington area and is discussing franchise options and other rapid growth opportunities.
About View Systems/Medical Therapeutics:
View Systems, Inc. is entering new and additional markets to include boutique medical clinics offering a variety of specialized procedures to appropriate patient demographics. Other View Systems' security products are used by commercial businesses and residential consumers wishing to monitor their assets and limit their liability. View Systems security scanners are installed at the Securities & Exchange Commission (SEC) Washington, DC headquarters as well as the public-school systems in a major U.S. cities. View Systems security products are Homeland Security approved.
Safe Harbor Statement:
This press release contains certain forward-looking statements. Investors are cautioned that certain statements in this release are "forward-looking statements" and involve both known and unknown risks, uncertainties and other factors. Such uncertainties include, among others, certain risks associated with the operation of the company described above. The Company's actual results could differ materially from expected results.
CONTACT:
Medical Therapeutics, www.maletherapeutics.com
410-449-3200
© 2018 GlobeNewswire, Inc. All Rights Reserved.
U.S. FDA Approves Gilead Sciences' (Nasdaq: GILD) Antiviral Veklury (remdesivir) for the Treatment of COVID-19
